Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, Skinvisible, Inc. reported revenue of $0M, up 0.0% year over year. Operating margin was -2481.6% and net margin -5320.2%, on a free-cash-flow margin of -212.5% with capital expenditure at 20.4% of revenue. Every figure is computed directly from SKVI's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $0M | -2481.6% | -5320.2% |
| FY2024 | $0M | -2947.9% | -2828.3% |
| FY2023 | $0M | -2451.9% | -11912.2% |
| FY2022 | $0M | -85.4% | -438.6% |
| FY2021 | $1M | 28.3% | -161.7% |
How does SKVI compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.